Bendamustine, Obinutuzumab and Venetoclax As Induction Therapy for Untreated Mantle Cell Lymphoma

This article has no abstract
Epistemonikos ID: c7b28c2f75a9510b51b451cd1fc2e60a31d98c87
First added on: Feb 12, 2025